Balance Sheet Akebia Therapeutics, Inc.

Stocks

AKBA

US00972D1054

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 12:00:05 2026-06-11 pm EDT			5-day change	1st Jan Change
0.8900 ^USD	+1.96%		-8.05%	-44.58%

Jun. 10	Akebia Therapeutics Secures New Patent Covering Dosing Regimen for Chronic Kidney Disease	MT
May. 07	Akebia Therapeutics, Inc., Q1 2026 Earnings Call, May 07, 2026

f7.gbpkBuvM2PSqDpmwt0spQWpfhlV5TwURmybKS6w7mjw.xMgQN5KKmZPGPeqA1nhdFAIY7wYgA3Fm6lKIDJ127Hjl3SIzv731jZNKqQ

Published financial data: AKEBIA THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	214M	293M	195M	160M	236M
Total Revenues	214M	293M	195M	160M	236M
Cost of Goods Sold, Total	83.65M	21.69M	39.76M	26.15M	40.35M
Gross Profit	130M	271M	155M	134M	196M
Selling General & Admin Expenses, Total	174M	139M	100M	107M	107M
R&D Expenses	148M	129M	63.08M	37.65M	62.36M
Amortization of Goodwill and Intangible Assets - (IS)	36.04M	36.04M	36.04M	36.04M	-
Other Operating Expenses, Total	358M	304M	199M	180M	170M
Operating Income	-228M	-32.94M	-44.5M	-46.21M	26M
Interest Expense, Total	-20.02M	-15.69M	-6.03M	-18.18M	-24.18M
Interest And Investment Income	66K	-	-	-	-
Net Interest Expenses	-19.95M	-15.69M	-6.03M	-18.18M	-24.18M
Other Non Operating Income (Expenses)	2.41M	3.15M	887K	-236K	-3.04M
EBT, Excl. Unusual Items	-246M	-45.48M	-49.64M	-64.63M	-1.22M
Restructuring Charges	-	-15.93M	-181K	-58K	-
Merger & Related Restructuring Charges	-21.58M	-	-	-	-
Gain (Loss) On Sale Of Investments	15K	-	-	-	-
Asset Writedown	-15.62M	-30.24M	-1.58M	-4.21M	-2.5M
Other Unusual Items	-	-906K	-524K	-517K	-
EBT, Incl. Unusual Items	-283M	-92.56M	-51.92M	-69.41M	-3.72M
Income Tax Expense	-	-	-	-	1.62M
Earnings From Continuing Operations	-283M	-92.56M	-51.92M	-69.41M	-5.34M
Net Income to Company	-283M	-92.56M	-51.92M	-69.41M	-5.34M
Net Income - (IS)	-283M	-92.56M	-51.92M	-69.41M	-5.34M
Net Income to Common Incl Extra Items	-283M	-92.56M	-51.92M	-69.41M	-5.34M
Net Income to Common Excl. Extra Items	-283M	-92.56M	-51.92M	-69.41M	-5.34M
Per Share Items
Net EPS - Basic	-1.7	-0.51	-0.28	-0.33	-0.02
Basic EPS - Continuing Operations	-1.7	-0.51	-0.28	-0.33	-0.02
Basic Weighted Average Shares Outstanding	166M	183M	187M	211M	257M
Net EPS - Diluted	-1.7	-0.51	-0.28	-0.33	-0.02
Diluted EPS - Continuing Operations	-1.7	-0.51	-0.28	-0.33	-0.02
Diluted Weighted Average Shares Outstanding	166M	183M	187M	211M	257M
Normalized Basic EPS	-0.93	-0.16	-0.17	-0.19	-0
Normalized Diluted EPS	-0.93	-0.16	-0.17	-0.19	-0
Supplemental Items
EBITDA	-190M	4.76M	-6.87M	-8.7M	27.27M
EBITA	-192M	3.1M	-8.45M	-10.16M	26M
EBIT	-228M	-32.94M	-44.5M	-46.21M	26M
EBITDAR	-183M	10.06M	-1.47M	-3.7M	32.27M
Total Revenues (As Reported)	214M	293M	195M	160M	236M
Effective Tax Rate - (Ratio)	-	-	-	-	-43.64
Current Domestic Taxes	-	-	-	-	1.62M
Total Current Taxes	-	-	-	-	1.62M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	-154M	-28.43M	-31.02M	-40.39M	-760K
Interest on Long-Term Debt	10.9M	9.5M	6M	7.1M	8.4M
Supplemental Operating Expense Items
Advertising Expense	8.2M	6.7M	1M	4.6M	7.6M
Selling and Marketing Expenses	8.2M	6.7M	1M	4.6M	7.6M
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	148M	129M	99.08M	73.65M	62.36M
Net Rental Expense, Total	6.7M	5.3M	5.4M	5M	5M
Imputed Operating Lease Interest Expense	6.8M	3.84M	1.99M	4.37M	4.99M
Imputed Operating Lease Depreciation	-103K	1.46M	3.41M	631K	8.36K
Stock-Based Comp., COGS (Total)	-	-	267K	399K	683K
Stock-Based Comp., R&D Exp. (Total)	5.82M	3.68M	1.96M	1.5M	2.12M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	16.92M	10.97M	6.46M	5.84M	8.48M
Stock-Based Comp., Other (Total)	-	3.2M	630K	38K	-
Total Stock-Based Compensation	22.74M	17.85M	9.32M	7.78M	11.28M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	150M	90.47M	42.92M	51.87M	185M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	150M	90.47M	42.92M	51.87M	185M
Accounts Receivable, Total	55.18M	39.96M	39.29M	34.37M	47.03M
Total Receivables	55.18M	39.96M	39.29M	34.37M	47.03M
Inventory	38.2M	21.76M	15.69M	16.24M	15.61M
Prepaid Expenses	26.83M	30.06M	14.49M	4.03M	-
Restricted Cash	-	-	-	-	1.7M
Other Current Assets, Total	2M	2.7M	5.75M	7.32M	3.77M
Total Current Assets	272M	185M	118M	114M	253M
Gross Property Plant And Equipment	48.27M	43.69M	-	-	-
Accumulated Depreciation	-7.66M	-9.32M	-	-	-
Net Property Plant And Equipment	40.61M	34.37M	16.04M	10.42M	4.88M
Goodwill	55.05M	55.05M	59.04M	59.04M	59.04M
Other Intangibles, Total	108M	72.08M	36.04M	0	-
Other Long-Term Assets, Total	49.75M	5.37M	12.42M	37.38M	59.68M
Total Assets	526M	352M	242M	221M	377M
Liabilities
Accounts Payable, Total	33.59M	18.02M	14.64M	15.18M	21.18M
Accrued Expenses, Total	99.65M	63.5M	42.94M	33.27M	92.12M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	97.54M	32M	19.55M	4.31M	19.02M
Current Portion of Leases	4.8M	4.74M	4.49M	5.4M	3.55M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	20.91M	3.74M	-	-	2.68M
Other Current Liabilities	-	2.75M	18.26M	22.75M	24.38M
Total Current Liabilities	256M	125M	99.87M	80.91M	163M
Long-Term Debt	53.08M	91.56M	71.2M	175M	176M
Long-Term Leases	33.7M	28.96M	8.95M	3.55M	-
Unearned Revenue Non Current	21.47M	43.3M	43.3M	-	-
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	84.34M	53.91M	48.98M	9.92M	4.8M
Total Liabilities	449M	342M	272M	270M	344M
Common Stock, Total	1K	2K	2K	2K	2K
Additional Paid In Capital	1.54B	1.56B	1.58B	1.63B	1.72B
Retained Earnings	-1.46B	-1.55B	-1.61B	-1.68B	-1.68B
Comprehensive Income and Other	6K	6K	6K	6K	6K
Total Common Equity	76.46M	9.34M	-30.58M	-49.18M	32.61M
Total Equity	76.46M	9.34M	-30.58M	-49.18M	32.61M
Total Liabilities And Equity	526M	352M	242M	221M	377M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	181M	184M	209M	236M	268M
ECS Total Common Shares Outstanding	177M	184M	195M	225M	265M
Book Value / Share	0.43	0.05	-0.16	-0.22	0.12
Tangible Book Value	-86.72M	-118M	-126M	-108M	-26.43M
Tangible Book Value Per Share	-0.49	-0.64	-0.65	-0.48	-0.1
Total Debt	189M	157M	104M	189M	199M
Net Debt	39.33M	66.8M	61.26M	137M	13.94M
Debt Equivalent Oper. Leases	53.6M	42.4M	43.2M	40M	40M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Work In Process, Total	-	-	4.3M	12.03M	12.65M
Inventories - Finished Goods, Total	-	-	11.39M	4.21M	2.96M
Machinery, Total	5.85M	5.85M	-	-	-
Full Time Employees	426	204	167	181	194
Part Time Employees	-	1	-	-	-
Assets under Capital Lease - Gross	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	1M	1.2M	2.69M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-283M	-92.56M	-51.92M	-69.41M	-5.34M
Depreciation & Amortization - CF	1.93M	1.65M	5.8M	5.66M	1.27M
Amortization of Goodwill and Intangible Assets - (CF)	36.04M	36.04M	36.04M	36.04M	-
Depreciation & Amortization, Total	37.97M	37.7M	41.85M	41.7M	1.27M
(Gain) Loss From Sale Of Asset	-	-	-	-	-172K
(Gain) Loss on Sale of Investments - (CF)	-15K	-	-	-	-
Asset Writedown & Restructuring Costs	-	8.77M	782K	-	-
Stock-Based Compensation (CF)	22.74M	17.85M	9.32M	7.78M	11.28M
Provision and Write-off of Bad Debts	-	-	-	876K	1.48M
Other Operating Activities, Total	77.6M	-43.47M	-2.68M	18.07M	43.01M
Change In Accounts Receivable	-24.02M	11.7M	994K	4.05M	-14.14M
Change In Inventories	-25.85M	19.79M	-2.54M	-28.4M	-23.12M
Change In Accounts Payable	-11.74M	1.5M	-5.24M	-1.36M	3.08M
Change in Unearned Revenues	1.82M	4.65M	-3.74M	-	2.68M
Change in Other Net Operating Assets	-48.64M	-39.08M	-10.2M	-13.96M	47.98M
Cash from Operations	-253M	-73.15M	-23.38M	-40.66M	67.99M
Capital Expenditure	-59K	-114K	-	-33K	-291K
Sale of Property, Plant, and Equipment	-	-	-	-	172K
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-7.81M
Investment in Marketable and Equity Securities, Total	40M	-	-	-	-
Cash from Investing	39.94M	-114K	-	-33K	-7.93M
Long-Term Debt Issued, Total	-	-	-	45M	10M
Total Debt Issued	-	-	-	45M	10M
Long-Term Debt Repaid, Total	-	-33M	-32M	-37.1M	-4.23M
Total Debt Repaid	-	-33M	-32M	-37.1M	-4.23M
Issuance of Common Stock	88.95M	7.6M	6.79M	43.03M	68.36M
Repurchase of Common Stock	-	-	-	-	-
Other Financing Activities, Total	44.78M	40M	-	-1.27M	-1.21M
Cash from Financing	134M	14.6M	-25.21M	49.66M	72.93M
Net Change in Cash	-79.29M	-58.67M	-48.59M	8.97M	133M
Supplemental Items
Cash Interest Paid	9.63M	6.76M	6.06M	5.04M	6.08M
Levered Free Cash Flow	-142M	-13.37M	22.11M	17.83M	68.61M
Unlevered Free Cash Flow	-129M	-3.56M	25.88M	29.2M	83.73M
Change In Net Working Capital	47.18M	38.41M	-2.53M	-8.63M	-63.02M
Net Debt Issued / Repaid	-	-33M	-32M	7.9M	5.77M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-24.38	-4.69	-9.3	-12.49	5.44
Return on Total Capital	-44.59	-9.53	-23.56	-22.81	8.76
Return On Equity %	-174.55	-215.77	409.6	174.03	64.49
Return on Common Equity	-174.55	-215.77	409.6	174.03	64.49
Margin Analysis
Gross Profit Margin %	60.83	92.59	79.57	83.68	82.92
SG&A Margin	81.54	47.4	51.5	66.52	45.5
EBITDA Margin %	-89.03	1.63	-3.53	-5.43	11.55
EBITA Margin %	-89.94	1.06	-4.34	-6.35	11.01
EBIT Margin %	-106.81	-11.26	-22.86	-28.85	11.01
Income From Continuing Operations Margin %	-132.43	-31.63	-26.68	-43.33	-2.26
Net Income Margin %	-132.43	-31.63	-26.68	-43.33	-2.26
Net Avail. For Common Margin %	-132.43	-31.63	-26.68	-43.33	-2.26
Normalized Net Income Margin	-71.89	-9.71	-15.94	-25.22	-0.32
Levered Free Cash Flow Margin	-66.31	-4.57	11.36	11.13	29.05
Unlevered Free Cash Flow Margin	-60.45	-1.22	13.3	18.23	35.45
Asset Turnover
Asset Turnover	0.37	0.67	0.65	0.69	0.79
Fixed Assets Turnover	5.61	7.81	7.72	12.11	30.87
Receivables Turnover (Average Receivables)	5.1	6.15	4.89	4.35	5.8
Inventory Turnover (Average Inventory)	1.69	0.72	2.13	1.64	2.53
Short Term Liquidity
Current Ratio	1.06	1.48	1.18	1.41	1.55
Quick Ratio	0.8	1.05	0.82	1.07	1.42
Operating Cash Flow to Current Liabilities	-0.99	-0.59	-0.23	-0.5	0.42
Days Sales Outstanding (Average Receivables)	71.57	59.34	74.62	84.15	62.89
Days Outstanding Inventory (Average Inventory)	216.46	504.55	171	223.5	144.06
Average Days Payable Outstanding	224.71	1.79K	175.87	204.36	167.08
Cash Conversion Cycle (Average Days)	63.31	-1.23K	69.75	103.3	39.87
Long Term Solvency
Total Debt/Equity	247.37	1.68K	-340.64	-383.71	609.57
Total Debt / Total Capital	71.21	94.39	141.56	135.25	85.91
LT Debt/Equity	113.51	1.29K	-262.04	-363.96	540.37
Long-Term Debt / Total Capital	32.68	72.34	108.89	128.29	76.15
Total Liabilities / Total Assets	85.45	97.34	112.65	122.29	91.34
EBIT / Interest Expense	-11.4	-2.1	-7.38	-2.54	1.08
EBITDA / Interest Expense	-9.16	0.64	-0.24	-0.2	1.33
(EBITDA - Capex) / Interest Expense	-9.17	0.63	-0.24	-0.21	1.32
Total Debt / EBITDA	-1.03	15.64	-70.97	-50.98	6.16
Net Debt / EBITDA	-0.21	6.64	-41.73	-36.97	0.43
Total Debt / (EBITDA - Capex)	-1.03	15.82	-70.97	-50.53	6.22
Net Debt / (EBITDA - Capex)	-0.21	6.72	-41.73	-36.64	0.44
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-27.68	37	-33.46	-17.7	47.46
Gross Profit, 1 Yr. Growth %	-43.84	108.51	-42.64	-13.45	46.12
EBITDA, 1 Yr. Growth %	36.79	-102.5	-324.75	26.7	-413.41
EBITA, 1 Yr. Growth %	36.14	-101.62	-703.01	20.24	-355.84
EBIT, 1 Yr. Growth %	32.17	-85.56	28.45	3.85	-156.28
Earnings From Cont. Operations, 1 Yr. Growth %	-26.24	-67.27	-44.89	33.67	-92.3
Net Income, 1 Yr. Growth %	-26.24	-67.27	-44.89	33.67	-92.3
Normalized Net Income, 1 Yr. Growth %	36.73	-81.49	5.21	30.19	-98.12
Diluted EPS Before Extra, 1 Yr. Growth %	-38.46	-70.29	-46.15	18.79	-93.68
Accounts Receivable, 1 Yr. Growth %	93.12	-27.59	-2.47	-12.53	36.85
Inventory, 1 Yr. Growth %	-37.4	-43.02	-27.25	3.52	-3.9
Net Property, Plant and Equip., 1 Yr. Growth %	14.39	-15.35	-53.32	-35.07	-53.11
Total Assets, 1 Yr. Growth %	-18.41	-33.05	-32.12	-8.7	70.65
Tangible Book Value, 1 Yr. Growth %	-279.2	35.83	-0.18	-13.88	-75.58
Common Equity, 1 Yr. Growth %	-69.12	-87.78	-684.78	60.82	-166.3
Cash From Operations, 1 Yr. Growth %	129.16	-71.08	-68.03	73.88	-267.22
Capital Expenditures, 1 Yr. Growth %	-81.39	93.22	-	-	781.82
Levered Free Cash Flow, 1 Yr. Growth %	691.4	-90.56	-244.5	-19.36	403.23
Unlevered Free Cash Flow, 1 Yr. Growth %	947.87	-97.24	-570.65	12.8	234.9
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-20.15	-0.46	-4.11	-26	10.16
Gross Profit, 2 Yr. CAGR %	-24.78	8.22	9.08	-29.54	12.46
EBITDA, 2 Yr. CAGR %	-11.09	-81.5	-80.98	68.75	99.27
EBITA, 2 Yr. CAGR %	-11.05	-85.17	-79.01	169.27	75.39
EBIT, 2 Yr. CAGR %	-9.6	-56.31	-55.81	15.49	-23.55
Earnings From Cont. Operations, 2 Yr. CAGR %	0.57	-50.87	-57.09	-14.17	-67.92
Net Income, 2 Yr. CAGR %	0.57	-50.87	-57.09	-14.17	-67.92
Normalized Net Income, 2 Yr. CAGR %	-6.33	-49.68	-55.03	17.04	-84.35
Diluted EPS Before Extra, 2 Yr. CAGR %	-15.06	-57.24	-59.41	-20.45	-72.61
Accounts Receivable, 2 Yr. CAGR %	19.16	18.26	-16.16	-7.63	9.41
Inventory, 2 Yr. CAGR %	-42.7	-40.28	-34.55	-13.22	-0.26
Net Property, Plant and Equip., 2 Yr. CAGR %	1.5	-1.6	-37.14	-44.95	-44.82
Total Assets, 2 Yr. CAGR %	-17.45	-26.09	-32.43	-21.27	24.82
Tangible Book Value, 2 Yr. CAGR %	33.73	56.01	16.14	-7.28	-54.14
Common Equity, 2 Yr. CAGR %	-55.99	-80.58	-35.72	206.67	3.26
Cash From Operations, 2 Yr. CAGR %	-0.87	-18.59	-69.6	-25.45	70.52
Capital Expenditures, 2 Yr. CAGR %	-90.58	-40.03	-	-46.2	-
Levered Free Cash Flow, 2 Yr. CAGR %	-14.42	-13.49	-59.68	7.95	95.81
Unlevered Free Cash Flow, 2 Yr. CAGR %	-18.28	-46.21	-54.23	130.41	96.58
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.93	-4.41	-12.91	-8.87	-6.88
Gross Profit, 3 Yr. CAGR %	-14.27	5.66	-12.44	0.98	-10.15
EBITDA, 3 Yr. CAGR %	3.61	-72.96	-63.38	-64.22	107.43
EBITA, 3 Yr. CAGR %	3.78	-76.62	-60.95	-62.44	164.72
EBIT, 3 Yr. CAGR %	9.58	-50.95	-36.59	-41.25	-9.12
Earnings From Cont. Operations, 3 Yr. CAGR %	25.35	-30.83	-48.71	-37.33	-61.58
Net Income, 3 Yr. CAGR %	25.35	-30.83	-48.71	-37.33	-61.58
Normalized Net Income, 3 Yr. CAGR %	13.42	-45.44	-35.1	-35.9	-70.46
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.68	-40.15	-53.47	-42.15	-65.81
Accounts Receivable, 3 Yr. CAGR %	49.05	0.93	11.2	-14.96	5.3
Inventory, 3 Yr. CAGR %	-30.6	-42.81	-36.41	-23.74	-10.22
Net Property, Plant and Equip., 3 Yr. CAGR %	71.69	-4.46	-23.26	-36.46	-47.81
Total Assets, 3 Yr. CAGR %	-19.21	-23.02	-27.87	-25.3	1.88
Tangible Book Value, 3 Yr. CAGR %	-29.99	34.43	37.45	5.12	-40.56
Common Equity, 3 Yr. CAGR %	-50.64	-71.29	-50.2	-12.73	84.06
Cash From Operations, 3 Yr. CAGR %	37.41	-34.26	-40.39	-45.63	-2.41
Capital Expenditures, 3 Yr. CAGR %	-66.76	-74.22	-	-17.61	36.67
Levered Free Cash Flow, 3 Yr. CAGR %	18.55	-58.96	7.12	-49.2	64.89
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.95	-73.58	27.74	-38.17	147.84
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	168.34	10.06	-1.3	-13.72	-4.33
Gross Profit, 5 Yr. CAGR %	142.95	8.37	-5.57	-10.21	-3.22
EBITDA, 5 Yr. CAGR %	6.91	-42.56	-47.42	-48.51	-27.88
EBITA, 5 Yr. CAGR %	7.08	-47.35	-45.25	-46.99	-28.78
EBIT, 5 Yr. CAGR %	10.82	-15.55	-23.82	-30.21	-31.67
Earnings From Cont. Operations, 5 Yr. CAGR %	15.81	4.67	-18.41	-24.32	-57.49
Net Income, 5 Yr. CAGR %	15.81	4.67	-18.41	-24.32	-57.49
Normalized Net Income, 5 Yr. CAGR %	12.63	-9.04	-21.67	-25.41	-63.26
Diluted EPS Before Extra, 5 Yr. CAGR %	-13.89	-21.45	-35.32	-32.58	-62.44
Accounts Receivable, 5 Yr. CAGR %	10.29	3.15	18.71	-2.43	10.48
Inventory, 5 Yr. CAGR %	-	-	-32.77	-32.55	-23.86
Net Property, Plant and Equip., 5 Yr. CAGR %	73.11	56.88	14.87	-23.37	-32.74
Total Assets, 5 Yr. CAGR %	11.85	-0.69	-24.67	-22.14	-10.18
Tangible Book Value, 5 Yr. CAGR %	4.95	-0.79	-13.04	17.42	-11.39
Common Equity, 5 Yr. CAGR %	2.34	-40.24	-45.5	-34.07	-33.33
Cash From Operations, 5 Yr. CAGR %	34.3	5.43	-24.84	-30.87	-9.24
Capital Expenditures, 5 Yr. CAGR %	-53.32	-41.2	-	-65.4	-1.7
Levered Free Cash Flow, 5 Yr. CAGR %	61.62	-5.57	-23.61	-37.92	30.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	58.65	-27.51	-21.16	-31.48	46.48